(Circulation. 1997;95:1806-1812.)
© 1997 American Heart Association, Inc.
Articles |
the Clinica Medica Generale e Cardiologia, Florence, Italy.
Correspondence to Prof G.G. Neri Serneri, Clinica Medica Generale e Cardiologia, Viale Morgagni, 85, 50134 Florence, Italy.
Background Recent studies suggest a role for inflammation in the pathophysiology of unstable angina. This study was designed to investigate whether circulating lymphocytes are involved in the inflammatory reaction associated with the episodes of unstable angina.
Methods and Results Twenty-nine patients with proven unstable angina, 36 with stable angina, and 30 healthy subjects were studied. Both early and short-lived (interleukin-2 receptor [IL-2R],
-chain CD25, and transferrin receptor CD71) and late antigen (HLA-DR) expression were investigated by flow cytometric analysis. Soluble IL-2R (sIL-2R) was also measured in plasma by ELISA. Lymphocyte activation was studied at day 1 of hospital admission and after 7, 15, 30, 60, and 90 days. In patients with unstable angina, the number of HLA-DR+ CD3 lymphocytes and levels of sIL-2R were higher (P<.001) than in patients with stable angina and control subjects. Both CD4+ and CD8+ lymphocytes expressed HLA-DR antigens. No differences were found among the different groups of subjects in regard to the expression of CD25 and CD71. Lymphocyte activation was more marked in patients with urgent revascularization. No relationships were found between the number of HLA-DR+ lymphocytes and either the severity of coronary angiographic lesions or the number of ischemic episodes. Observations over time showed a gradual decrease in the number of HLA-DR+ lymphocytes and sIL-2R levels from weeks 3 through 8 to 12.
Conclusions The present results indicate that (1) CD4+ and CD8+ circulating lymphocytes are activated in patients with unstable angina, and their activation state lasts 6 to 8 weeks; and (2) activation of lymphocytes is not a consequence of myocardial ischemia. These results support the immune systemmediated inflammatory nature of unstable angina.
Key Words: angina interleukins lymphocytes immune system coronary disease
This article has been cited by other articles:
![]() |
T Adachi, T Naruko, A Itoh, R Komatsu, Y Abe, N Shirai, H Yamashita, S Ehara, M Nakagawa, C Kitabayashi, et al. Neopterin is associated with plaque inflammation and destabilisation in human coronary atherosclerotic lesions Heart, December 1, 2007; 93(12): 1537 - 1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Caligiuri and A. Nicoletti Lymphocyte responses in acute coronary syndromes: lack of regulation spawns deviant behaviour Eur. Heart J., November 1, 2006; 27(21): 2485 - 2486. [Full Text] [PDF] |
||||
![]() |
S Ranjit and L Dazhu Potential role of dendritic cells for progression of atherosclerotic lesions. Postgrad. Med. J., September 1, 2006; 82(971): 573 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sharma and D.-Z. Li Role of Dendritic Cells in Atherosclerosis Asian Cardiovasc Thorac Ann, April 1, 2006; 14(2): 166 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Caligiuri, E. Groyer, J. Khallou-Laschet, A. A. H. Zen, J. Sainz, D. Urbain, A.-T. Gaston, M. Lemitre, A. Nicoletti, and A. Lafont Reduced Immunoregulatory CD31+ T Cells in the Blood of Atherosclerotic Mice With Plaque Thrombosis Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1659 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kohsaka, V. Menon, A. M. Lowe, M. Lange, V. Dzavik, L. A. Sleeper, J. S. Hochman, and for the SHOCK Investigators Systemic Inflammatory Response Syndrome After Acute Myocardial Infarction Complicated by Cardiogenic Shock Arch Intern Med, July 25, 2005; 165(14): 1643 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Methe, S. Brunner, D. Wiegand, M. Nabauer, J. Koglin, and E. R. Edelman Enhanced T-Helper-1 Lymphocyte Activation Patterns in Acute Coronary Syndromes J. Am. Coll. Cardiol., June 21, 2005; 45(12): 1939 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ceriello Acute hyperglycaemia: a 'new' risk factor during myocardial infarction Eur. Heart J., February 2, 2005; 26(4): 328 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ceriello Insulin, Glycemic Control, and C-Reactive Protein During Myocardial Infarction Diabetes Care, December 1, 2004; 27(12): 3017 - 3018. [Full Text] [PDF] |
||||
![]() |
M. Madjid, A. Zarrabi, S. Litovsky, J. T. Willerson, and W. Casscells Finding Vulnerable Atherosclerotic Plaques: Is It Worth the Effort? Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1775 - 1782. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Falk Widespread Targets for Friendly Fire in Acute Coronary Syndromes Circulation, July 6, 2004; 110(1): 4 - 6. [Full Text] [PDF] |
||||
![]() |
R. Marfella, M. Siniscalchi, K. Esposito, A. Sellitto, U. de Fanis, C. Romano, M. Portoghese, S. Siciliano, F. Nappo, F. C. Sasso, et al. Effects of Stress Hyperglycemia on Acute Myocardial Infarction: Role of inflammatory immune process in functional cardiac outcome Diabetes Care, November 1, 2003; 26(11): 3129 - 3135. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J de Boer, A. E Becker, and A. C van der Wal T lymphocytes in atherogenesis--functional aspects and antigenic repertoire Cardiovasc Res, October 15, 2003; 60(1): 78 - 86. [Full Text] [PDF] |
||||
![]() |
S.-P. Yang, L.-J. Ho, Y.-L. Lin, S.-M. Cheng, T.-P. Tsao, D.-M. Chang, Y.-L. Hsu, C.-Y. Shih, T.-Y. Juan, and J.-H. Lai Carvedilol, a new antioxidative {beta}-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-{kappa}B activity Cardiovasc Res, September 1, 2003; 59(3): 776 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Soejima, A. Irie, S. Miyamoto, I. Kajiwara, S. Kojima, J. Hokamaki, T. Sakamoto, T. Tanaka, M. Yoshimura, Y. Nishimura, et al. Preference Toward a T-Helper Type 1 Response in Patients With Coronary Spastic Angina Circulation, May 6, 2003; 107(17): 2196 - 2200. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Semb, S. van Wissen, T. Ueland, T. Smilde, T. Waehre, M. D. Tripp, S. S. Froland, J. J. P. Kastelein, L. Gullestad, T. R. Pedersen, et al. Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy J. Am. Coll. Cardiol., January 15, 2003; 41(2): 275 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Oldgren, L Wallentin, L Grip, R Linder, B.L Norgaard, and A Siegbahn Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease Eur. Heart J., January 1, 2003; 24(1): 86 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Spagnoli, E. Bonanno, A. Mauriello, G. Palmieri, A. Partenzi, G. Sangiorgi, and F. Crea Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1579 - 1588. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Marx, B. Kehrle, K. Kohlhammer, M. Grub, W. Koenig, V. Hombach, P. Libby, and J. Plutzky PPAR Activators as Antiinflammatory Mediators in Human T Lymphocytes: Implications for Atherosclerosis and Transplantation-Associated Arteriosclerosis Circ. Res., April 5, 2002; 90(6): 703 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stollberger and J. Finsterer Role of Infectious and Immune Factors in Coronary and Cerebrovascular Arteriosclerosis Clin. Vaccine Immunol., March 1, 2002; 9(2): 207 - 215. [Full Text] [PDF] |
||||
![]() |
N T Mulvihill and J B Foley Inflammation in acute coronary syndromes Heart, March 1, 2002; 87(3): 201 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maseri and D. Cianflone Inflammation in acute coronary syndromes Eur. Heart J. Suppl., March 1, 2002; 4(suppl_B): B8 - B13. [Abstract] [PDF] |
||||
![]() |
C D Garlichs, S Eskafi, D Raaz, A Schmidt, J Ludwig, M Herrmann, L Klinghammer, W G Daniel, and A Schmeisser Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets Heart, December 1, 2001; 86(6): 649 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Zalai, M. D. Kolodziejczyk, L. Pilarski, A. Christov, P. N. Nation, M. Lundstrom-Hobman, W. Tymchak, V. Dzavik, D. P. Humen, W. J. Kostuk, et al. Increased circulating monocyte activation in patients with unstable coronary syndromes J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1340 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Monaco, F. Crea, G. Niccoli, F. Summaria, D. Cianflone, R. Bordone, G. Bellomo, and A. Maseri Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications Eur. Heart J., September 1, 2001; 22(17): 1572 - 1577. [Abstract] [PDF] |
||||
![]() |
J.C. Kaski and E.G. Zouridakis Inflammation, infection and acute coronary plaque events Eur. Heart J. Suppl., August 1, 2001; 3(suppl_I): I10 - I15. [Abstract] [PDF] |
||||
![]() |
G. G. Neri Serneri, M. Boddi, L. Poggesi, I. Simonetti, M. Coppo, M. L. Papa, G. F. Lisi, M. Maccherini, R. Becherini, A. Boncompagni, et al. Activation of cardiac renin-angiotensin system in unstable angina J. Am. Coll. Cardiol., July 1, 2001; 38(1): 49 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. De Lorenzo, A. Noorani, and V.V. Kakkar Current trends in the management of thromboembolic events QJM, April 1, 2001; 94(4): 179 - 185. [Full Text] [PDF] |
||||
![]() |
P.a. Aukrust, R. K. Berge, T. Ueland, E. Aaser, J. K. Damas, L. Wikeby, A. Brunsvig, F. Muller, K. Forfang, S. S. Froland, et al. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes J. Am. Coll. Cardiol., February 1, 2001; 37(2): 485 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Caligiuri, G. Paulsson, A. Nicoletti, A. Maseri, and G. K. Hansson Evidence for Antigen-Driven T-Cell Response in Unstable Angina Circulation, September 5, 2000; 102(10): 1114 - 1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liuzzo, J. J. Goronzy, H. Yang, S. L. Kopecky, D. R. Holmes, R. L. Frye, and C. M. Weyand Monoclonal T-Cell Proliferation and Plaque Instability in Acute Coronary Syndromes Circulation, June 27, 2000; 101(25): 2883 - 2888. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nakagomi, S. B. Freedman, and C. L. Geczy Interferon-{gamma} and Lipopolysaccharide Potentiate Monocyte Tissue Factor Induction by C-Reactive Protein : Relationship With Age, Sex, and Hormone Replacement Treatment Circulation, April 18, 2000; 101(15): 1785 - 1791. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Garcia-Moll, F. Coccolo, D. Cole, and J. C. Kaski Serum neopterin and complex stenosis morphology in patients with unstable angina J. Am. Coll. Cardiol., March 15, 2000; 35(4): 956 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
X Garcia-Moll, D Cole, E Zouridakis, and J C Kaski Increased serum neopterin: a marker of coronary artery disease activity in women Heart, March 1, 2000; 83(3): 346 - 350. [Abstract] [Full Text] |
||||
![]() |
V. Pasceri and E. T. H. Yeh A Tale of Two Diseases : Atherosclerosis and Rheumatoid Arthritis Circulation, November 23, 1999; 100(21): 2124 - 2126. [Full Text] [PDF] |
||||
![]() |
G. Liuzzo, L. M. Biasucci, J. R. Gallimore, G. Caligiuri, A. Buffon, A. G. Rebuzzi, M. B. Pepys, and A. Maseri Enhanced inflammatory response in patients with preinfarction unstable angina J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1696 - 1703. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Aukrust, F. Muller, T. Ueland, T. Berget, E. Aaser, A. Brunsvig, N. O. Solum, K. Forfang, S. S. Froland, and L. Gullestad Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina : Possible Reflection of T Lymphocyte and Platelet Involvement in the Pathogenesis of Acute Coronary Syndromes Circulation, August 10, 1999; 100(6): 614 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. H. M. Verheggen, M. P. M. de Maat, V. M. Cats, F. Haverkate, A. H. Zwinderman, C. Kluft, and A. V. G. Bruschke Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function Eur. Heart J., April 2, 1999; 20(8): 567 - 574. [Abstract] [PDF] |
||||
![]() |
D. A. Halon, M. Y. Flugelman, A. Merdler, H. Rennert, J. Shahla, and B. S. Lewis Long-term (10-year) outcome in patients with unstable angina pectoris treated by coronary balloon angioplasty J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1603 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Caligiuri, G. Liuzzo, L. M. Biasucci, and A. Maseri Immune system activation follows inflammation in unstable angina: pathogenetic implications J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1295 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
A C van der Wal, J J Piek, O J de Boer, K T Koch, P Teeling, C M van der Loos, and A E Becker Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes Heart, July 1, 1998; 80(1): 14 - 18. [Abstract] [Full Text] |
||||
![]() |
N. Marx, B. Kehrle, K. Kohlhammer, M. Grub, W. Koenig, V. Hombach, P. Libby, and J. Plutzky PPAR Activators as Antiinflammatory Mediators in Human T Lymphocytes: Implications for Atherosclerosis and Transplantation-Associated Arteriosclerosis Circ. Res., April 5, 2002; 90(6): 703 - 710. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |